Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK, has launched a crowd-sourced marketplace for the life science community to exchange knowledge.
The portal, named Ximbio, which was created by Cyber-Duck following a competitive pitch, is an online biological tools or ‘reagents’ portal, focused on all areas of biology to help to support and advance life science research.
The reagents are invented to solve scientific problems, and Ximbio has been developed to address barriers in sharing or selling these on to other scientists for use in their own experiments; including time and resource challenges, inconsistencies in reagent data, difficulty identifying suitable reagents for commercialisation as well as problems retaining the link between each reagent and its originating inventor.
The new portal will enable researchers to more easily link together in one place, facilitating a more streamlined commercialisation process.
Cyber-Duck worked closely with CRT to create the Ximbio brand, delivering the new name, logo design, art direction and tone of voice.
Melanie Hardman PHD, head of Ximbio commented: “In the future, Ximbio will offer reagent types that haven’t even been invented yet, so the design had to be incredibly flexible. We selected Cyber-Duck following a competitive tender, and have been delighted by the team’s dedication and agile approach, delivering a great product in tight timelines and on budget.”
The first release of Ximbio has now been launched with over 900 reagents, developed in universities across the country.